Signaling Pathways
Product Name | CAS No. | Specification | Application | Registration |
Cobimetinib (GDC-0973; XL518) | 934660-93-2 | |||
(+)-PD 128907 Hydrochloride | 300576-59-4 | |||
Trabectedin (Ecteinascidin 743) & Intermediates | 114899-77-3 | |||
Temsirolimus (CCI-779) | 162635-04-3 | 98% Min. | ||
Alvespimycin (17-DMAG) HCl | 467214-21-7 | |||
Reparixin L-lysine salt (Repertaxin L-lysine salt) | 266359-93-7 | 98%+;ee-98%+ | ||
Resatorvid (TAK-242) | 243984-11-4 | In-House Standard | ||
Y-27632 Dihydrochloride | 129830-38-2 | In-House Standard | ||
Temoporfin | 122341-38-2 | In-House Standard | ||
Brefeldin A | 20350-15-6 | |||
Verteporfin | 129497-78-5 | |||
Ansamitocin P-3 | 66584-72-3 | |||
Capsiate | 205687-01-0 |
Products
- All
- Pharmaceutical Intermediates
- Active Pharmaceutical Ingredients
- Drug Impurities & Metabolites
- Novel Life Science Reagents
- Signaling Pathways
- Inhibitory Antibodies
- Bioactive Small Molecules
- Screening Compounds
- Stable Isotope Labelled Compounds
- COVID-19 Related Inhibitors
- Amino Acids & Vitamins
- Natural Products
- Health & Nutritional Ingredients
- Pharmaceutical Excipients
- Specialty Chemicals & Building Blocks